enVVeno Medical Corporation Overview
Pro stress-test →enVVeno Medical is a clinical-stage medical device company focused on bioprosthetic tissue-based solutions for venous disease treatment. Its lead product is the VenoValve, a replacement venous valve designed to treat chronic venous insufficiency.
Strategic Profile
Pro stress-test →As a late clinical-stage company, enVVeno is developing both surgical and non-surgical replacement venous valves for severe chronic venous insufficiency in the deep venous system. The company is positioned to establish itself as a global leader in severe deep venous disease treatment.
Competitive Landscape
Pro stress-test →The market for chronic venous insufficiency treatment is substantial and represents a significant opportunity, with enVVeno positioning itself to lead in severe, deep venous disease treatment through recent media attention around the disease. Key competitors in the broader interventional device space include established cardiovascular device manufacturers, though specific venous valve competitors are limited.
Industry Context
enVVeno Medical Corporation operates in Medical Devices - Cardiovascular/Venous Intervention.
Key facts
Founded: 1999 · Headquarters: Irvine, US · Employees: 37 · Market cap: $6.5M